Today: 17 May 2026
Lightwave Logic Stock Drop Puts $51 Million Share-Sale Plan and AI Optics Push in Focus

Lightwave Logic Stock Drop Puts $51 Million Share-Sale Plan and AI Optics Push in Focus

ENGLEWOOD, Colorado, April 26, 2026, 10:01 MDT

Lightwave Logic shares pulled back in the latest U.S. trading session, putting fresh attention on the company’s expanded stock-sale program and its still-early push to turn electro-optic polymer technology into commercial revenue. LWLG last traded at $12.665, down about 6.9%, after swinging between $11.905 and $14.21 on volume of about 11.0 million shares.

The move matters because the company is raising and preserving cash while investors weigh a large valuation against a business that remains mostly pre-commercial. Lightwave reported 2025 net sales of $236,855 and a net loss of $20.3 million, while saying it does not expect significant revenue from volume commercial production until 2027 at the earliest.

Lightwave said in a filing last week that it amended its sales agreement with Roth Capital Partners to lift the amount of common stock that may be sold under the program to $51.4 million. An at-the-market, or ATM, program lets a company sell shares into the market from time to time through an agent; it can add cash but may dilute existing holders.

The company said it had already sold 8.08 million shares under the agreement for gross proceeds of about $35 million. A separate prospectus supplement filed with the Securities and Exchange Commission registered up to $49.3 million of common stock for possible sale under the amended arrangement.

Lightwave is trying to commercialize electro-optic polymers, materials that use an electrical signal to control light and are aimed at moving data faster with lower power use. Its model is not to build full optical modules, but to sell materials, license intellectual property and support process design kits, or PDKs — the files and rules chip designers use to prepare a design for manufacturing.

Recent foundry work is the core of the bull case. Lightwave said in March that its high-speed modulator platform had been added to a GDSFactory PDK supporting GlobalFoundries’ silicon photonics platform, with validation tape-outs targeting 200G and 400G per lane applications. Chief Executive Yves LeMaitre called the PDK availability a “significant step toward commercial deployment.” company-998002.suite.accessnewswire.com

GDSFactory CTO Joaquin Matres said the collaboration gives designers access to “validated, high-performance modulator building blocks.” GlobalFoundries’ Dr. Patrick Lo said work with ecosystem partners helps support “next-generation photonic solutions” for data-center and high-bandwidth uses. company-998002.suite.accessnewswire.com

Lightwave also signed a development agreement with Tower Semiconductor in March to integrate its modulator reference designs into Tower’s PH18 silicon photonics PDK. Tower executive Dr. Ed Priesler said the agreement expands “modulator options” for customers, while LeMaitre said the work could lower the barrier for customers to create photonic products. company-998002.suite.accessnewswire.com

The competitive backdrop is not quiet. Lightwave’s own 10-K lists conventional silicon modulators, thin-film lithium niobate and III-V compound semiconductor devices such as indium phosphide as rival approaches in optical modulation, a field where bigger and better funded companies can move fast.

Cash is better than it was. The company ended 2025 with $69.0 million in cash and cash equivalents and said its current cash position could fund operations at least through December 2027, though it expects about $2.4 million in monthly expenditures over the next 12 months.

But the downside case is plain. Customer programs may not move from prototypes to production, qualification can take longer than expected, and wider adoption depends on yield, cost, reliability and foundry capacity. The company also said there is no assurance it can fully use the Roth sales agreement, and if funding or planned revenue falls short it may have to limit operations.

Investors will get a formal company forum next month. Lightwave has scheduled its annual shareholder meeting for May 21 at 10:00 a.m. Mountain Daylight Time, to be held virtually by audio webcast.

Stock Market Today

  • Monster Beverage (MNST) Stock Near Fair Value After Multi-Year Gains
    May 16, 2026, 9:18 PM EDT. Monster Beverage (MNST) has delivered strong returns, rising nearly 89% over five years. The stock recently traded at around $87, modestly above its estimated intrinsic value of $80.02 based on a Discounted Cash Flow (DCF) model. This valuation approach projects Monster's free cash flow growing from $1.94 billion to over $3 billion by 2030. Despite impressive share price gains, the DCF suggests Monster is roughly 8.8% overvalued, indicating current prices are close to fair value rather than significantly overpriced. While the company's position in the US energy drink market supports growth prospects, its valuation score was 0 out of 6 on standard metrics, urging caution for new investors. Traders should monitor valuation shifts and market developments to time entries appropriately.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Infleqtion Stock Faces a Fresh Test After 30.5 Million-Share Shift by Early Backers
Previous Story

Infleqtion Stock Faces a Fresh Test After 30.5 Million-Share Shift by Early Backers

Visa Inc. Stock Faces a Crucial Earnings Test After Wall Street Cuts Its Target
Next Story

Visa Inc. Stock Faces a Crucial Earnings Test After Wall Street Cuts Its Target

Go toTop